SCHEMBL31444261

SCHEMBL31444261

COC(=O)c1ccc(N2CC(O)CC2c2ccccc2Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
KDM4E B2RXH2 4/20 0.43
GLA P06280 4/20 0.43
GAA P10253 4/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
HPGD P15428 2/20 0.43
CASP1 P29466 2/20 0.43
CASP7 P55210 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MAPK1 P28482 2/20 0.43
TSHR P16473 2/20 0.43
PDE5A O76074 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
P2RX3 P56373 1/20 0.39
MAPT P10636 1/20 0.39
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
FFAR2 O15552 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31444309 0.84 ALDH1A1 (0.40) ALDH1A1KDM4EGLAGAAL3MBTL1
SCHEMBL31444288 0.83 NR1H4 (0.43) ALDH1A1KDM4EGLAGAAL3MBTL1
SCHEMBL31444227 0.80 ALDH1A1 (0.46) ALDH1A1KDM4EGLAGAAL3MBTL1
SCHEMBL31444501 0.79 PDE5A (0.43) ALDH1A1KDM4EGLAGAAL3MBTL1
SCHEMBL31444331 0.77 ALDH1A1 (0.41) ALDH1A1KDM4EGLAGAAL3MBTL1
SCHEMBL31444507 0.77 SMO (0.41) ALDH1A1KDM4EGLAGAAL3MBTL1
SCHEMBL31444342 0.73 RORC (0.43) KDM4EL3MBTL1PDE5AMEN1KMT2A
SCHEMBL31444516 0.71 NR1H4 (0.43) ALDH1A1KDM4EGLAGAAL3MBTL1
SCHEMBL27139334 0.69 RIPK1 (0.44) PDE5AMEN1KMT2AFFAR2
SCHEMBL31444482 0.68 RIPK1 (0.43) ALDH1A1TSHRPDE5AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072451-A1 RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES VIVIDION THERAPEUTICS, INC. (US) 2025-04-03 WO disclosed